<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
  • There are no suggestions because the search field is empty.

EORTC-NCI-AACR Symposium 2026 Posters

Meet us at Booth 30

18-20 November 2026 | Barcelona, Spain

We are excited to showcase our latest preclinical and translational oncology data and share how our services offer biotech and pharmaceutical companies the opportunity to remove the guesswork from their research and development. Schedule a meeting with our experts to discuss your needs further. 

Wednesday, November 18 | 12:00 - 19:00

110

Developing Different Preclinical RAS Inhibitor Resistant Xenograft Models for Next-Generation Therapeutic Evaluation

Location: PB-110
Topic: Drug Resistance and Modifiers
Platform: In vivo
Author: Aaron Hua

Thursday, November 19 | 9:00 -17:30

217

Integrated Organoid Screening Approaches Enable Preclinical Assessment of Protein Degrader Efficacy and Target Engagement

Location: PB-112
Topic: Molecular Targeted Agents
Platform: In vitro
Author: Marten Hornsveld

Friday, November 20 | 9:00 - 15:00

261

Characterization of a Panel of PDX Models Derived from c-MET Targeting ADCs Pretreated Colorectal Cancer Patients for Therapeutic Evaluation

Location: PB-053
Topic: Animal Models
Platform: In vivo
Author: Qingzhi Liu

262

Establishing Preclinical Mouse Models for Translational Cancer Cachexia Research

Location: PB-054
Topic: Animal Models
Platform: In vivo
Author: Aaron Hua

343

Medicines Discovery Catapult (MDC) Colaboration:

End-to-End In Vitro and In Vivo Evaluation of Radiopharmaceuticals in Patient-Derived Models

Location: PB-135
Author: Anita Liu, Bryan W. Miller, Antonella di Mambro, Prabhakar Panday, Rosemary Shoop, Esther Kingma, Chiara Da Pieve, Bhushan Rai, Juliana Maynard, Elisabet Fernandez-Potente, Bram Herpers, Lucy Harris, Lynne Braidwood, Ludovic Bourre, Benedetta Arno

345

Benchmarking Multiple Comparison Procedures for Patient-Derived Xenograft Tumor-Volume Studies

Location: PB-137
Topic: Preclinical Models
Platform: DSB/In vivo
Author: Binchen Mao

346

PDX-Derived Organoids Predict In Vivo Response Across KRAS Inhibitors and Antibody-Drug Conjugates

Location: PB-138
Topic: Preclinical Models
Platform: DSB/In vivo
Author: Binchen Mao

Share This

Schedule time to meet with us

Your privacy is important to us.
We'll never share your information.